Evidence map›Paper›PMID 32212784›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2020

The Possible Role of Adipokines in HCV Associated Hepatocellular Carcinoma.

Usama M El-Daly, Magdy M Saber, Mona S Abdellateif, Hanan R Nassar, Alfred E Namour, Yahia M Ismail, Abdel-Rhaman N Zekri

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Usama M El-DalyDepartment of Medical Oncology, Damietta Oncology Center, Damietta,, Egypt.
Magdy M SaberDepartment of Medical Oncology and Malignant Hematology, National Cancer Institute, Cairo University, Cairo, Egypt.
Mona S AbdellateifMedical Biochemistry and Molecular Biology, Cancer Biology Department, National Cancer Institute, Cairo University, Cairo, Egypt.ORCID 0000-0002-5510-4435
Hanan R NassarDepartment of Medical Oncology and Malignant Hematology, National Cancer Institute, Cairo University, Cairo, Egypt.
Alfred E NamourDepartment of Medical Oncology and Malignant Hematology, National Cancer Institute, Cairo University, Cairo, Egypt.
Yahia M IsmailDepartment of Medical Oncology and Malignant Hematology, National Cancer Institute, Cairo University, Cairo, Egypt.
Abdel-Rhaman N ZekriMolecular Virology and Immunology Unit, Department of Cancer Biology, National Cancer Institute, Cairo University, Cairo, Egypt.
Cairo University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAdipokines play an important role in the regulation of inflammation and tumor progression.

aimAssessment of the possible role of adiponectin, leptin and visfatin in HCV associated hepatocellular carcinoma (HCC).

methodspatients were classified into 85 patients with HCV associated HCC, 100 patients with chronic hepatitis C viral (HCV) infection compared to 50 normal control (NC) subjects. All subjects included in the study were assessed for HCV infection by seropositive HCV antibodies, as well as HCV RNA by RT-PCR. Serum levels of adiponectin, leptin and visfatin were assessed using enzyme linked immunosorbent assay (ELISA). The data were correlated to the relevant clinic-pathological features of the patients, and the overall survival (OS) rate.

resultsThere was a significant difference in the serum levels of adiponectin and visfatin among HCC, HCV and NC groups (P<0.001). The serum levels of leptin and alpha fetoprotein (AFP) were significantly higher in HCC group (P<0.001). There was a significant association between the serum level of adiponectin and advanced Child class liver cirrhosis (P=0.03), as well as with poor performance status (ECOG, P=0.02). Serum leptin associated significantly with the number of lesions in the liver (P=0.006), visfatin associated with increased mortality rate (P<0.001). Adiponectin, leptin and visfatin associated significantly with liver cirrhosis in HCV patients (P<0.01). Leptin achieved the highest sensitivity (98.8%). visfatin achieved the highest specificity (100%) and PPV (100%) for detection of HCC. The combination of serum leptin and visfatin for the diagnosis of HCV associated HCC showed sensitivity, specificity, PPV, NPV and accuracy (100%, 96.6%, 93.4%, 100% and 97.4%; respectively).

conclusionAdiponectin, leptin and visfatin have an important role(s) in the pathogenesis of HCV associated HCC. <br />.

Indexed as

AdipokinesAgedBiomarkers, TumorCarcinoma, HepatocellularFemaleHepatitis CHumansLiver NeoplasmsMaleMiddle AgedNicotinamide PhosphoribosyltransferaseAdipokinesBiomarkers, TumorNicotinamide PhosphoribosyltransferaseAdipokinesAdiponectinHCCleptinVisfatin

Identifiers

PMID32212784
PMCPMC7437316
OpenAlexW3013484944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.